Name | GSK329 |
---|
Description | GSK329 is a potent and selective diarylurea inhibitor of the cardiac-specific kinase TNNI3K. GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury[1]. |
---|---|
Related Catalog | |
Target |
TNNI3K[1] |
References |
Molecular Formula | C19H14Cl2F3N5O2 |
---|---|
Molecular Weight | 472.25 |